Provided by Tiger Trade Technology Pte. Ltd.

Hillhouse Capital Related

448.627
-9.994-2.18%
Number of Gainers:15
Number of Losers:29
Number of Flat:7
PE:- -
High:463.212
Open:459.097
Low:445.839
Close:458.621
Volume:407.95M
Turnover:11.95B
Market Cap:2.88T
Float Cap:1.97T

Loading ...

EU Withdrawal of Aumseqa Exposes Hansoh Pharma's Compliance Gaps and Global Ambitions

Deep News
·
Sep 29

Beyond the Blind Spot: Three Core Signals That Reveal Blue Moon Group's Advanced Logic

Stock News
·
Sep 29

Asian Penny Stocks To Watch In September 2026

Simply Wall St.
·
Sep 29

US Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 28

Everest Medicines Forms ESG Committee

Stock News
·
Sep 28

Mindrank AI: Collaboration Covers Mainland China, Hong Kong and Macau, with a Total Potential Transaction Value of up to RMB 1.75 Bln (USD 260 Mln)

THOMSON REUTERS
·
Sep 28

Mindrank AI Ltd : Partners with 3SBio to Commercialize Its AI-Designed Oral Glp-1 in China

THOMSON REUTERS
·
Sep 28

Mindrank AI: Will be Eligible for up to RMB 1.6 Bln in Additional Milestone Payments

THOMSON REUTERS
·
Sep 28

JPMorgan Trims Stake in China Suntien Green Energy by 2.675 Million Shares at About HK$3.38 Each

Stock News
·
Sep 28

JPMorgan Trims Stake in Fuyao Glass by About 935,300 Shares at Roughly HK$55.36 Each

Stock News
·
Sep 28

Innovent Biologics Gets China Nod for Jaypirca to Treat Chronic Lymphocytic Leukemia

MT Newswires Live
·
Sep 28

Jaypirca® (Pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (Cll) /Small Lymphocytic Lymphoma (Sll) Across All Lines of Therapy

Reuters
·
Sep 28

Instant Retail Enters the "Product Era," Meituan's Official Flagship Lightning Warehouses Become a New Growth Channel for Brands

Deep News
·
Sep 28

Ming Yuan Cloud (00909) Spends HKD 925,400 to Repurchase 1 Million Shares on September 28

Stock News
·
Sep 28

Antengene-B (06996) Repurchases 90,000 Shares for HK$303,300 on September 28

Stock News
·
Sep 28

Innovent's Jaypirca (pirtobrutinib) wins NMPA approval for all-line CLL/SLL treatment in China

Stock News
·
Sep 28

Innovent Biologics - Jaypirca (Pirtrobrutinib) Approved in China for Cll/Sll Across All Lines of Therapy

THOMSON REUTERS
·
Sep 28

3SBIO Spends HK$20.41 Million to Buy Back 1.3 Million Shares on September 28

Stock News
·
Sep 28

AK Medical Spends HK$242,000 on Buyback of 50,000 Shares on September 28

Stock News
·
Sep 28

JD Health International Stock Rises 1.3% in Hong Kong

Dow Jones
·
Sep 28